3 items3 sources2 stocks
Seeking Alpha-Nov 6, 04:55 PM
Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027
Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027(摘要待生成)
Zacks-Nov 5, 10:22 PM
Starling Oncology, Inc. (STLN) Reports Q3 Loss, Beats Revenue Estimates - Zacks Investment Research
Starling Oncology, Inc. (STLN) Reports Q3 Loss, Beats Revenue Estimates - Zacks Investment Research(摘要待生成)